◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
RaQualia Pharma Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ3 2025Aug 14, 2025Q4 2024Dec 31, 2024Q3 2024Aug 21, 2024Q3 2024Aug 14, 2024Q4 2023Dec 31, 2023Q4 2022Dec 31, 2022Q4 2021Dec 31, 2021
+Operating Income -154.2M -- -23.4M -23.4M -- -- --
Operating Margin % 55.6% -- -63.6% -63.6% -- -- --
+Ordinary Income -277.5M -- 36.7M 36.7M -- -- --
Revenue Growth % -- -- 0.0% -- -- -- --
Line ItemQ3 2025Aug 14, 2025Q4 2024Dec 31, 2024Q3 2024Aug 21, 2024Q3 2024Aug 14, 2024Q4 2023Dec 31, 2023Q4 2022Dec 31, 2022Q4 2021Dec 31, 2021
Current Assets 4.5B -- 5.0B 5.0B -- -- --
Total Assets 9.7B 10.7B 6.9B 6.9B 7.0B 5.2B 4.6B
Current Liabilities 1.2B -- 389.3M 389.3M -- -- --
Total Liabilities 4.1B 4.7B 751.5M 751.5M 706.3M 524.6M 410.2M
Total Equity 5.6B 6.0B 6.1B 6.1B 6.3B 4.7B 4.2B
Equity Ratio -- 0.56 -- -- 0.90 0.90 0.91
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...